The authors will discuss their recently published NEJM articles, "Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis" and "Nerandomilast in Patients with Progressive Pulmonary Fibrosis", and their impact on clinical management of patients with interstitial lung diseases. We will be joined by authors Justin Oldham, MD, University of Michigan, Toby Maher, MD, University of Southern California, and Marlies Wijsenbeek, MD, Erasmus MC, University Medical Center, as well moderators and Ayodeji Adegunsoye, MD, University of Chicago, and Carla Copeland, MD, University of Alabama at Birmingham.
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis: A Journal Club Discussion of the FIBRONEER-IPF and FIBRONEER-ILD Trials
-
When
Monday, November 17 11:00 am — 12:00 pm EST -
Where
Online -
Type
Assembly Webinars & Podcasts
Note:
Outlook Live is for personal accounts (e.g., @outlook.com, @hotmail.com, @live.com), while Office 365 is for work accounts via Microsoft 365.